Gunawardana CG
No ORCID on file
· 2 papers in corpus
2010
ObjectivesNew ovarian cancer biomarkers suitable for early disease diagnosis, prognosis or monitoring could improve patient management and outcomes.Design and methodsNidogen-2 was measured by immunoassay in serum of 100 healthy women, 100 w…
2009
Current ovarian cancer biomarkers are inadequate because of their relatively low diagnostic sensitivity and specificity. There is a need to discover and validate novel ovarian cancer biomarkers that are suitable for early diagnosis, monitor…